Correlation Between Recursion Pharmaceuticals and 456837AW3

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and 456837AW3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and 456837AW3 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and ING GROEP NV, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 456837AW3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 456837AW3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 456837AW3.

Diversification Opportunities for Recursion Pharmaceuticals and 456837AW3

-0.13

Correlation Coefficient

Recursion Pharmaceuticals  456837AW3

Good diversification

The 3 months correlation between Recursion and 456837AW3 is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and ING GROEP NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ING GROEP NV and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 456837AW3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ING GROEP NV has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 456837AW3 go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and 456837AW3

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 24.44 times more return on investment than 456837AW3. However, Recursion Pharmaceuticals is 24.44 times more volatile than ING GROEP NV. It trades about 0.13 of its potential returns per unit of risk. ING GROEP NV is currently generating about 0.0 per unit of risk. If you would invest  610.00  in Recursion Pharmaceuticals on September 19, 2024 and sell it today you would earn a total of  102.00  from holding Recursion Pharmaceuticals or generate 16.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.48%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  ING GROEP NV

Recursion Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

ING GROEP NV

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ING GROEP NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 456837AW3 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Recursion Pharmaceuticals and 456837AW3

The main advantage of trading using opposite Recursion Pharmaceuticals and 456837AW3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 456837AW3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 456837AW3 will offset losses from the drop in 456837AW3's long position.

The idea behind Recursion Pharmaceuticals and ING GROEP NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.